Truist Financial Initiates Coherus BioSciences(CHRS.US) With Buy Rating

Futu NewsNov 19 20:33 · Ratings

Barclays Maintains Coherus BioSciences(CHRS.US) With Buy Rating, Maintains Target Price $7

Futu NewsNov 18 17:33 · Ratings

Coherus Biosciences (CHRS) Receives a Buy From Barclays

TipRanksNov 18 17:07 · Ratings

Baird Maintains Coherus BioSciences(CHRS.US) With Buy Rating, Cuts Target Price to $4

Futu NewsNov 8 20:35 · Ratings

Baird Maintains Outperform on Coherus BioSciences, Lowers Price Target to $4

BenzingaNov 8 20:27 · Ratings

Coherus Stock Rallies 19% on Q3 Earnings, Udenyca Production Update

Seeking AlphaNov 8 04:56